3 days Ago By ABMN Staff
Beyond Air, Inc. ( NASDAQ:XAIR – Get Free Report ) was the target of a large drop in short interest in August. As of August 31st, there was short interest totalling 597,300 shares, a drop of 20.
0% from the August 15th total of 747,000 shares. Based on an average trading volume of 815,700 shares, the short-interest ratio is currently 0.7 days.
Insider Buying and Selling In other news, CEO Steven A. Lisi acquired 100,000 shares of the stock in a transaction on Wednesday, August 14th. The stock was acquired at an average cost of $0.
39 per share, for a total transaction of $39,000.00. Following the completion of the transaction, the chief executive officer now directly owns 1,722,785 shares in the company, valued at $671,886.
15. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link . 19.
00% of the stock is currently owned by company insiders. Hedge Funds Weigh In On Beyond Air A number of hedge funds have recently made changes to their positions in XAIR. Rosalind Advisors Inc.
acquired a new stake in Beyond Air during the 1st quarter valued at approximately $1,572,000. Gendell Jeffrey L increased its position in shares of Beyond Air by 30.4% during the first quarter.
Gendell Jeffrey L now owns 1,461,071 shares of the company’s stock worth $2,542,000 after buying an additional 340,774 shares during the period. Point72 Asia Singapore Pte. Ltd.
acquired a new stake in shares of Beyond Air during the second quarter worth $47,000. Finally, Vanguard Group Inc. raised its stake in Beyond Air by 5.
0% during the first quarter. Vanguard Group Inc. now owns 1,399,298 shares of the company’s stock worth $2,435,000 after buying an additional 66,224 shares during the last quarter.
31.50% of the stock is currently owned by institutional investors. Beyond Air Stock Up 6.
6 % Beyond Air ( NASDAQ:XAIR – Get Free Report ) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.27) earnings per share for the quarter, topping the consensus estimate of ($0.
39) by $0.12. The company had revenue of $0.
68 million for the quarter, compared to analysts’ expectations of $0.72 million. Beyond Air had a negative net margin of 3,272.
46% and a negative return on equity of 240.15%. During the same quarter in the previous year, the firm posted ($0.
45) earnings per share. On average, research analysts anticipate that Beyond Air will post -1.03 earnings per share for the current year.
Analysts Set New Price Targets XAIR has been the subject of a number of research reports. Roth Mkm reissued a “buy” rating and issued a $2.00 target price on shares of Beyond Air in a report on Friday, August 16th.
BTIG Research downgraded shares of Beyond Air from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 25th. Piper Sandler decreased their target price on shares of Beyond Air from $3.50 to $1.
00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. Finally, Roth Capital upgraded Beyond Air to a “strong-buy” rating in a research note on Friday, August 16th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company.
Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $3.67.
View Our Latest Stock Analysis on Beyond Air About Beyond Air ( Get Free Report ) Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.
Further Reading Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter ..
